Vistagen Therapeutics, Inc. (VTGN)
0.5299
-0.01
(-1.47%)
USD |
NASDAQ |
Jun 10, 16:00
0.5471
+0.02
(+3.25%)
After-Hours: 20:00
Vistagen Therapeutics Market Cap : 21.00M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 21.31M |
| June 08, 2026 | 21.29M |
| June 05, 2026 | 21.55M |
| June 04, 2026 | 22.81M |
| June 03, 2026 | 22.19M |
| June 02, 2026 | 22.98M |
| June 01, 2026 | 25.66M |
| May 29, 2026 | 24.96M |
| May 28, 2026 | 25.09M |
| May 27, 2026 | 24.73M |
| May 26, 2026 | 25.23M |
| May 22, 2026 | 25.63M |
| May 21, 2026 | 25.24M |
| May 20, 2026 | 25.35M |
| May 19, 2026 | 24.96M |
| May 18, 2026 | 23.59M |
| May 15, 2026 | 24.76M |
| May 14, 2026 | 25.78M |
| May 13, 2026 | 25.98M |
| May 12, 2026 | 24.63M |
| May 11, 2026 | 26.69M |
| May 08, 2026 | 24.19M |
| May 07, 2026 | 23.25M |
| May 06, 2026 | 24.19M |
| May 05, 2026 | 23.78M |
| Date | Value |
|---|---|
| May 04, 2026 | 24.66M |
| May 01, 2026 | 24.79M |
| April 30, 2026 | 24.30M |
| April 29, 2026 | 23.61M |
| April 28, 2026 | 23.64M |
| April 27, 2026 | 22.64M |
| April 24, 2026 | 23.53M |
| April 23, 2026 | 22.58M |
| April 22, 2026 | 23.87M |
| April 21, 2026 | 23.99M |
| April 20, 2026 | 24.12M |
| April 17, 2026 | 24.87M |
| April 16, 2026 | 23.90M |
| April 15, 2026 | 24.22M |
| April 14, 2026 | 23.77M |
| April 13, 2026 | 22.82M |
| April 10, 2026 | 22.20M |
| April 09, 2026 | 22.02M |
| April 08, 2026 | 21.80M |
| April 07, 2026 | 21.23M |
| April 06, 2026 | 21.50M |
| April 02, 2026 | 23.24M |
| April 01, 2026 | 23.80M |
| March 31, 2026 | 22.64M |
| March 30, 2026 | 21.62M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.636B |
| Alnylam Pharmaceuticals, Inc. | 38.87B |
| Savara, Inc. | 1.041B |
| Vericel Corp. | 1.910B |
| Biogen, Inc. | 28.67B |
Market Cap Related Metrics
| PS Ratio | 17.93 |
| PEG Ratio | -0.0064 |
| Price to Book Value | 0.4124 |
| Price | 0.5299 |
| Earnings Yield | -362.7% |
| PEGY Ratio | -0.0064 |